Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers

Neurology. 2005 Dec 27;65(12):1971-3. doi: 10.1212/01.wnl.0000188821.51055.52.

Abstract

The authors studied four patients with parkinsonism carrying the fragile X premutation using SPECT with ([23)I]FP-CIT. They found evidence of preserved presynaptic nigrostriatal function, suggesting that parkinsonism in the X fragile premutation might be related to postsynaptic dopaminergic changes or different neurotransmitter alterations.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Aged
  • Atrophy / diagnostic imaging
  • Atrophy / genetics
  • Atrophy / metabolism
  • Biomarkers
  • Brain / diagnostic imaging
  • Brain / metabolism*
  • Brain / physiopathology
  • Brain Mapping
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / metabolism
  • Corpus Striatum / physiopathology
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins / metabolism*
  • Female
  • Fragile X Syndrome / genetics*
  • Genetic Predisposition to Disease / genetics
  • Heterozygote*
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics
  • Neural Pathways / diagnostic imaging
  • Neural Pathways / metabolism
  • Neural Pathways / physiopathology
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / metabolism
  • Substantia Nigra / physiopathology
  • Synaptic Transmission / genetics
  • Syndrome
  • Tomography, Emission-Computed, Single-Photon
  • Tropanes

Substances

  • Biomarkers
  • Dopamine Plasma Membrane Transport Proteins
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
  • Dopamine